Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid
US11236121B2 · kind B2 · utility
14Cited by
7References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2017 |
| Grant date | Feb 1, 2022 |
| Priority date | — |
| Expiry date | Aug 23, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) and crystalline solid forms and compositions thereof. Also disclosed herein are methods of making crystalline solid forms of the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) and methods of using the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) or crystalline solid forms, pharmaceutically acceptable salts, and pharmaceutically acceptable compositions thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.